Microsurgical resection of brain metastases: rationale, appropriateness and local control

Authors:

Али Хасьянович Бекяшев,

Сергей Михайлович Банов,

Сергей Рустамович Ильялов,

Елена Рэмовна Ветлова,

Алексей Владимирович Смолин,

Александр Алексеевич Тушев,

Давид Арамович Халафян

Журнал: Вопросы нейрохирургии имени Н.Н. Бурденко. 2026;90(5):106-112.

DOI: 10.17116/neiro202690051106

Read: 881 раз

Download PDF (EN)

Abstract

OBJECTIVE

To summarize data on indications for microsurgical resection of brain metastases, effect of resection technique on local control and leptomeningeal dissemination, as well as the role of stereotactic radiosurgery in improving local control.

MATERIAL AND METHODS

A descriptive review of data on surgical treatment of brain metastases was performed. We reviewed the PubMed/MEDLINE, the Cochrane Library (CENTRAL), PubMed Central, and eLIBRARY/RSCI databases between 2000 and January 2025 using the keywords “brain metastases”, “en bloc resection”, “piecemeal resection”, “local control”, “leptomeningeal disease”, “preoperative SRS” and “postoperative SRS”. Clinical studies, systematic reviews, meta-analyses, guidelines, and consensus documents were included. Studies on primary central nervous system tumors, samples ≤10 patients, and publications without extractable clinical outcomes were excluded.

RESULTS

The first part of the review considers indications for microsurgical resection in relation to clinical goals, survival and functional status. Surgery is reasonable for symptomatic large lesions, mass effect, diagnostic uncertainty, local recurrence, or complications after radiotherapy. Surgical technique should account for growth pattern of brain metastases: en bloc resection and, in selected cases, extended resection of peritumoral zone may improve local control. Retrospective data consistently associate piecemeal resection with higher risk of leptomeningeal dissemination, particularly for posterior fossa lesions and metastases adjacent to cerebrospinal fluid pathways.

CONCLUSION. S

Urgical treatment is presented as a component of a personalized multimodal strategy. Decision-making on surgery should rely on survival prognosis and likelihood of clinically meaningful benefit. When technically feasible, en bloc resection may be considered as a preferable approach, especially when the risk of leptomeningeal dissemination is clinically relevant.

Keywords

brain metastases
microsurgical resection
en bloc resection
local control
leptomeningeal dissemination
stereotactic radiosurgery

Конфликт интересов

The authors declare no conflicts of interest.

Дата поступления: 15.04.2026

Дата принятия в печать: 20.07.2026

Дата публикации: 16.10.2026

References

Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro-Oncology. 2021;23(9):1447-1456. https://doi.org/10.1093/neuonc/noab101
Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro-Oncology. 2022;24(10):1613-1646. https://doi.org/10.1093/neuonc/noac118
Ferguson SD, Wagner KM, Prabhu SS, McAleer MF, McCutcheon IE, Sawaya R. Neurosurgical management of brain metastases. Clinical & Experimental Metastasis. 2017;34(6-7):377-389. https://doi.org/10.1007/s10585-017-9860-z
Pintea B, Baumert B, Kinfe TM, Gousias K, Parpaley Y, Boström JP. Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts. Radiation Oncology. 2017;12(1):177. https://doi.org/10.1186/s13014-017-0917-6
Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg M, Barker FG, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discovery. 2015;5(11):1164-1177. https://doi.org/10.1158/2159-8290.CD-15-0369
Koffer P, Chan J, Rava P, Gorovets D, Ebner D, Savir G, Kinsella T, Cielo D, Hepel JT. Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurgery. 2017;104:589-593. https://doi.org/10.1016/j.wneu.2017.04.103
Patel U, Patel A, Cobb C, Benkers T, Vermeulen S. The management of brain necrosis as a result of SRS treatment for intra-cranial tumors. Translational Cancer Research. 2014;3(4):373-382. https://doi.org/10.3978/j.issn.2218-676X.2014.07.05
Vogelbaum MA, Suh JH. Resectable brain metastases. Journal of Clinical Oncology. 2006;24(8):1289-1294. https://doi.org/10.1200/JCO.2005.04.6235
Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? International Journal of Radiation Oncology, Biology, Physics. 2000;46(2):297-302. https://doi.org/10.1016/S0360-3016(99)00416-2
Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman W, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. International Journal of Radiation Oncology, Biology, Physics. 1997;37(4):745-751. https://doi.org/10.1016/S0360-3016(96)00619-0
Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. International Journal of Radiation Oncology, Biology, Physics. 2010;77(3):655-661. https://doi.org/10.1016/j.ijrobp.2009.08.025
Winther RR, Hjermstad MJ, Skovlund E, Aass N, Helseth E, Kaasa S, Yri OE, Vik-Mo EO. Surgery for brain metastases-impact of the extent of resection. Acta Neurochirurgica. 2022;164(10):2773-2780. https://doi.org/10.1007/s00701-021-05104-7
Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G. Postoperative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. The Lancet Oncology. 2017;18(8):1040-1048. https://doi.org/10.1016/S1470-2045(17)30414-X
Suki D, Hatiboglu MA, Patel AJ, Weinberg JS, Groves MD, Mahajan A, Sawaya R. Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery. 2009;64(4):664-676. https://doi.org/10.1227/01.NEU.0000341535.53720.3E
Salvati M, Cervoni L, Caruso R, Gagliardi FM. Solitary cerebral metastasis from melanoma: value of the en bloc resection. Clinical Neurology and Neurosurgery. 1996;98(1):12-14. https://doi.org/10.1016/0303-8467(95)00077-7
Siam L, Bleckmann A, Chaung HN, Mohr A, Klemm F, Barrantes-Freer A, Blazquez R, Wolff HA, Lüke F, Rohde V, Stadelmann C, Pukrop T. The metastatic infiltration at the metastasis/brain parenchyma interface is very heterogeneous and has a significant impact on survival in a prospective study. Oncotarget. 2015;6(30):29254-29267. https://doi.org/10.18632/oncotarget.4201
Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJM, Debougnoux-Huppertz RMTL, Lambin P, Kubat B. A pathology-based substrate for target definition in radiosurgery of brain metastases. International Journal of Radiation Oncology, Biology, Physics. 2006;66(1):187-194. https://doi.org/10.1016/j.ijrobp.2006.03.050
Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, Zo JI, Lee SH. Reduced local recurrence of a single brain metastasis through microscopic total resection. Journal of Neurosurgery. 2009;110(4):730-736. https://doi.org/10.3171/2008.8.JNS08448
Patel AJ, Suki D, Hatiboglu MA, Abouassi H, Shi W, Wildrick DM, Lang FF, Sawaya R. Factors influencing the risk of local recurrence after resection of a single brain metastasis. Journal of Neurosurgery. 2010;113(2):181-189. https://doi.org/10.3171/2009.11.JNS09659
Byun J, Kim JH, Kim M, Lee S, Kim YH, Hong CK, Kim JH. Survival outcomes and predictors for recurrence of surgically treated brain metastasis from non-small cell lung cancer. Brain Tumor Research and Treatment. 2022;10(3):172-182. https://doi.org/10.14791/btrt.2022.0016
Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. Journal of Neurosurgery. 2008;108(2):248-257. https://doi.org/10.3171/JNS/2008/108/2/0248
Ahn JH, Lee SH, Kim S, Joo J, Yoo H, Lee S, Shin SH, Gwak HS. Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. Journal of Neurosurgery. 2012;116(5):984-993. https://doi.org/10.3171/2012.1.JNS111560
Tewarie IA, Jessurun CAC, Hulsbergen AFC, Smith TR, Mekary RA, Broekman MLD. Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis. Neuro-Oncology Advances. 2021;3(1):vdab162. https://doi.org/10.1093/noajnl/vdab16